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Available online 4 February 2017Connexins (Cxs) are integral membrane proteins that form high-conductance plasma membrane channels,
allowing communication from cell to cell (via gap junctions) and from cells to the extracellular environment
(via hemichannels). Initially described for their role in joining excitable cells (nerve and muscle), gap junctions
(GJs) are found between virtually all cells in solid tissues and are essential for functional coordination by enabling
the direct transfer of small signalling molecules, metabolites, ions, and electrical signals from cell to cell. Several
studies have revealeddiverse channel-independent functions of Cxs, which include the control of cell growth and
tumourigenicity. Connexin43 (Cx43) is themostwidespreadCx in the humanbody. Themyriad roles of Cx43 and
its implication in the development of disorders such as cancer, inflammation, osteoarthritis and Alzheimer's dis-
ease have given rise to many novel questions. Several RNA- and DNA-binding motifs were predicted in the Cx43
and Cx26 sequences using different computational methods. This review provides insights into new, ground-
breaking functions of Cxs, highlighting important areas for future work such as transfer of genetic information
through extracellular vesicles. We discuss the implication of potential RNA- and DNA-binding domains in the
Cx43 and Cx26 sequences in the cellular communication and control of signalling pathways.








Connexins (Cxs) and pannexins in vertebrates and innexins in inver-
tebrates are a family of proteins involved in cell to cell and cell to the ex-
tracellular space communication [1,2]. In humans, 21 isoforms of the Cx
multigene family have been identified [3]. Cxs show cell-type-specific
but overlapping patterns of expression, as well as shared topology and
functions, such that some Cxs can functionally replace others [4].3, connexin43; CL, cytoplasmic
wth factor receptor variant III;
, gap junction intercellular
ondrial DNA; NMR, nuclear
-M4, transmembrane domains;
IBIC, CH-Universitario A Coruña
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M.D. Mayan).
.V. This is an open access article undHowever, genetically modified animal models have demonstrated that
distinct properties and functions of Cxs [5] make them largely non-in-
terchangeable [4,6].
Cx hemichannels (connexons) consist of a hexameric unit of six Cxs.
Hemichannels allow the direct exchange of molecules and metabolites
with the extracellular matrix. Gap junction (GJ) channels are formed
by the apposition of connexons from adjacent cells and allow direct ex-
change between contacting cells. Cxs are known to play a role in cellular
functions such as cell guidance, cellular adhesion and cell growth, in
both gap junction-dependent and gap junction-independent manners.
Cx43 is the most completely characterized Cx isoform in terms of its
channel gating properties, identified phosphorylation sites, protein in-
teractions and channel assembly and turnover. Cx43 consists of 382
amino acids (Fig. 1A) and has versatile functional properties reflected
by its distribution in multiple tissues and cell types [7,8]. Cx43 is a con-
ditional tumour suppressor gene and participates in the synchronous
contraction of muscle cells, bone remodelling, embryonic developmenter the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Schematic representation of Connexin43 and the predicted RNA-binding domains. (A) Topological diagram of the Cx43 structure, with an N-terminal end, four transmembrane
domains (M1–M4), two extracellular loops (E1, E2), an intracellular loop (CL) and the C-terminal domain (CTD). The membrane region is shown in light green. Yellow circles
represent extracellular cysteine residues. Amino acid sequences in which the three computational methods coincide to predict RNA binding propensity are shown in red. (B) Amino
acid sequence of Cx43 with the predicted representation of three computational methods. aaRNA in red (highest score), PPRint (SVM threshold: −0.2) underlined and BindN+
(specificity: 85%) in bold. (C) Amino acid residue alignment between the CTD of Cx43 of Rattus norvegicus and Homo sapiens. Amino acid substitutions are shown in red. Gaps are
shown in green. (D) Topological diagram of the CTD of Cx43 of R. norvegicus. RNA binding propensity (amino acid sequence) predicted by the three computational methods is shown
in red. Below, sequence alignment between part of the CTD of rat and human with the predicted representation of three computational methods. aaRNA in blue and red, PPRint
underlined and BindN+ in bold (E) Ribbon model of the CTD structure (top) and hydrophobicity surface (bottom) according to the Kyte and Doolittle scale with values ranging from
blue (hydrophilic) to orange red (hydrophobic) [115]. The red dashed circles highlight the predicted RNA-binding domains.
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broad functional spectrum of Cx43 is the rare disease oculodentodigital
dysplasia, caused by mutations in the Cx43 gene (GJA1), which affects
the shape and function of many different parts of the body [9].2. Horizontal transfer through membrane vesicles
The transmission of information between cells in the body occurs
through several mechanisms of communication, such as the secretion
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cell to cell contacts mediated by GJs, tunnelling nanotubes that connect
cells, and membrane transfer by the secretion of membrane vesicles
generally referred to as microvesicles (MVs) (e.g., microparticles, apo-
ptotic blebs which can also contain cytosolic organelles and nuclear
fragments, and exosomes) [10].
The biogenesis and properties ofmicrovesicles (see Fig. 3B) include a
diverse group of membrane vesicles that share common characteristics
and participate in intercellular communication as membrane-derived
particles [11]. These MVs increase the complexity of cell signalling by
transmitting direct information via the proteins, lipids, nucleic acids
and other components that they contain, which can directly alter signal-
ling in the recipient cell. Horizontal transfer to recipient cells occurs
through the fusion or internalization of MVs [12–14]. However, the
transfer of compounds also occurs through membrane adhesion and
transport by “sticky” vesicles and GJs [15–19].
MVs are highly effective delivery vehicles and may contain genetic
material in the formofmRNAs ormicroRNAs that are transmitted by in-
tercellular communication, including those involved in tumourigenesis,
growth, division, differentiation or stress responses. MVs are known to
play a role in pathology by promoting tumour growth [20], stimulating
the autoimmune response in rheumatoid arthritis [21], transporting
proteins and RNA such as EGFRvIII mRNA in clinically distinct subtypes
of glioblastoma [22], and spreading viruses or prions [23–26] among
dozens of other functions such as reprogramming target cells and tissue
repair [27].
Thousands of mRNAs and hundreds of miRNAs have been found in-
side exosomes. Some studies have suggested that there is a selective
loading of specific mRNAmolecules into exosomes [28]. In addition,mi-
tochondrial DNA (mtDNA) has been found in the exosomes of astro-
cytes, myoblasts and glioblastoma cells [29–31]. Interestingly,
exosome-delivered RNAs mediate de novo transcriptional and transla-
tional changes in recipient cells [32]. In a report published in 2007, it
was demonstrated that exosome-mediated transfer can even occur be-
tween mouse exosomes containing mRNA and human mast cells,
resulting in the expression of mouse proteins in human cells [32].
A recent report has demonstrated that Cx43 controls the interaction
between exosomes containing Cx43 and recipient cells, favouring the
internalization of the vesicles [18]. This study also demonstrated that
exosomes and cells are able to exchange material through Cx channels,
similar to the ability of contacting cells to communicate through GJ
channels [18]. These results clearly suggest that Cx43 has pivotal and
differential roles in cellular communication mechanisms that occur
through membrane particles.
The horizontal transfer of coding and non-coding RNAs offers new
perspectives on intercellular communication, and has been already sug-
gested to have potential therapeutic applications in gene delivery. The
presence of Cxs onMVs, their ability to target cells and the increased ef-
ficacy of Cx43-expressing delivery particles [16,18] highlight the impor-
tance of this mechanism. It is important to note that tunnelling
nanotubes also provide cytoplasmic bridges between cells that may
allow the transfer of annular gap junctions (doublemembrane vesicles)
and MVs containing Cxs.3. Structural organization of connexins
All Cxs share the same structural arrangement consisting of four
transmembrane domains (M1–M4), two extracellular loops (E1–E2),
and three intracellular domains: one cytoplasmic loop (CL), the N-ter-
minus (NTD) and the C terminal domain (CTD) [5] (Fig. 1A). These
structural motifs were confirmed by solving the crystal structure of
the domains of Cx43 [33–35], human connexin26 (Cx26) and Cx26
hexameric GJ channels [36–39]. The X-ray structure of Cx26 solved by
Maeda et al. revealed structural details of different domains as well as
potential interactions between them [38]. These authors have describedthe diameter of the complete structure including the diameter of hydro-
philic GJ channels at the cytoplasmic surface.
It is predicted that the overall structure solved for the Cx26 protein
and Cx26 GJ channels are representative of the structures of all Cxs
and GJ channels since Cxs share sequence and topological homology.
However, the CTDs are the least conserved domains among Cxs and
have resisted crystallization, which suggests that CTDs are probably un-
structured and highly flexible [40].
3.1. Identified RNA-binding motifs in Cx43 and Cx26
The experimental determination of protein-RNA complexes is a
major challenge in structural biology due to difficulties associated
with their crystallization or resolution by nuclear magnetic resonance
spectroscopy (NMR). To solve this problem, many computational
methods have been developed and successfully used for predicting pro-
tein-RNA binding sites, using protein sequences and/or structural fea-
tures. Here we present several RNA-binding motifs predicted in the
Cx43 and Cx26 sequence using different computational methods. Our
analysis utilized three different programs with different criteria and
prediction accuracy and confirms the presence of at least ten potential
RNA-binding motifs in the sequence of human Cx43 (Fig. 1A–B and
Supp. Fig. 1A–C), including a motif in the N-terminal domain (NT),
one in the transmembrane domain M1, sequences located next to the
cysteine residues of each extracellular loop (E1 and E2), two separated
sequences in the cytoplasmic loop (CL) and three motifs in the CTD.
Fig. 1A–B and Supp. Fig. 1A show the homology modelling structure
depicting structural features predicted for the Cx43 protein and the
identified putative RNA-binding sites (aaRNA).
The aaRNA web server (https://sysimm.ifrec.osaka-u.ac.jp/aarna/)
uses a method that out-performs sequence or structure predictors by
combining in-line homologymodellingwith the features of the SRCPred
method and hidden Markov model (HMM)-based evolutionary conser-
vation scores for conservation evaluation, local relative accessible sur-
face area (rASA) and Laplacian norm (LN) coordinates to represent
molecular structure [41]. More than ten motifs (red) were identified
using the validated aaRNA method (Fig. 1B), out of which ten motifs
were selected based on their overall score, threshold and specificity.
Fig. 1A–B represent the Cx43 sequence and structure, highlighting the
common motifs that were independently predicted by the aaRNA
(red) and PPRint (underlined) (http://www.imtech.res.in/raghava/
pprint/) and BindN+ (bold) (http://bioinfo.ggc.org/bindn±/) pro-
grams [42,43]. BindN+ applies a machine learning method (SVM) to
the sequence-based prediction of DNA- or RNA-binding residues from
biochemical features (molecular mass, hydrophobicity, side chain pKa
values, among others) and evolutionary information. SVM is a widely
used algorithm for binary classification bymeans of supervised learning.
The BindN+ system performs a three-iteration PSI-BLAST search
against the UniProtKB database to derive evolutionary information.
Similarly, PPRint also accepts amino acid sequences as input and auto-
matically generates the evolutionary profile by running PSI-BLAST.
Like BindN+, it generates SVM patterns from the PSSM profile and pre-
dicts RNA interacting residues using an SVM model.
Out of all the domains of Cx43, only part of the structure of the CTD
(from rat) has been resolved to an atomic level [33,35,44,45]. An analy-
sis using the amino acid sequence and the structure of the rat CTD,
which has 98% sequence homology to human CTD (Fig. 1C), confirms
the same predicted RNA-binding motifs that we previously identified
for the human CTD sequence (Fig. 1B and D). The ribbon structure and
the hydrophilic (blue) and hydrophobic (red) faces are shown in Fig.
1E, with the predicted RNA-binding motifs indicated by dashed circles.
In contrast to Cx43, the structure of Cx26, the Cx26 connexon
(hemichannel) and the Cx26 GJ were resolved by cryo-electronmicros-
copy and X-ray crystallography to an atomic resolution [37,38,46–48],
providing valuable information for the prediction of RNA-binding
sites. Fig. 2A and Supp. Fig.1D represent the Cx26 topology and
Fig. 2. Predicted RNA-bindingmotifs in the Cx26 sequence. (A) Topological diagram of Cx26 amino acids and structure. Yellow circles represent extracellular cysteine residues. The amino
acid domains predicted to have RNA binding propensity by the three computationalmethods are shown in red. (B) Ribbonmodel of Cx26 structurewith the predicted RNA-bindingmotifs
in different colours. Light blue represents the NT–M1 domains; green, CL; red E1 and E2; yellow, cysteine residues. The motif predicted in the CTD is shown in purple. The extracellular
(above) and cytoplasmic (below) axial views are shown on the right. (C) Ribbon model of the hemichannel (connexon) structure formed by Cx26. The axial views for extracellular
(above) and cytoplasmic (below) are shown on the right. (D) Molecular surface showing the hydrophobicity values according to the Kyte and Doolittle scale [115]. The black dashed
circles show the location of the predicted RNA-binding motifs. (E) Density of the overall hydrophobicity on the molecular surface of the hemichannel [115].
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the aaRNA (red), PPRint (underlined) and BindN+(bold) computation-
al approaches (Supp. Fig. 1D). Concordantlywith thepredictions obtain-
ed for Cx43, the predicted RNA-bindingmotifs include those in theNTD,
M1, E1 and E2 loops next to cysteine residues, two separated sequences
in the CL and one motif in the CTD (Fig. 2A). The ribbon structure of
Cx26 indicating the position of the predicted RNA-binding motifs is
shown in Fig. 2B. Despite the accuracy of the prediction methods,
these putative RNA-bindingmotifs will require experimental validation
to confirm and understand such interactions.
An understanding of the sequence specificities of such interactions
and the identification of the RNA species bound to those domains willprovide essential information and new models of regulatory processes
and human diseases. Interestingly, the RNA-binding motifs found in
the C-loop (MRKEEKLNKKEEELKVA and GIEEHGKVKMRGGLLRTY) and
in the CTD of Cx43 (FKGVKDRVKGKSDPYHATSGALSPAK and
QRPSSRASSRASSRPR) are rich in arginines and lysines. Lysine- and argi-
nine-rich motifs have the highest propensity to bind with RNA. It has
been reported that individual arginine residues govern binding to an
RNA ligand, and the inherent flexibility of the peptide backbone may
make it possible for specific recognition of RNAs [49,50].
These sequences playmany critical roles in Cx43 function. For exam-
ple, QRPSSRASSRASSRPR sequence is a pivotal site of protein-protein in-
teractions [51]. This protein-RNA binding site (RPSSRASSRASSR) was
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Notably, the sequence contains several serine residues that are phos-
phorylated (e.g. S364, Ser365, S368, Ser369, S372, S373) by different ki-
nases (e.g. protein kinase C, protein kinase A, Ca + 2/calmodulin-
dependent kinase II) [52,53]. The phosphorylation and dephosphoryla-
tion of Cx43 can induce conformational changes and regulate the kinet-
ics of Cx channels assembly, gating and turnover [8,54]. Modification of
protein properties by post-translational modifications influences in the
protein activity, stability, subcellular localization and ability to interact
with other molecules (e.g. RNA or DNA) and proteins. The heteroge-
neous nuclear ribonucleoproteins A2B1 protein (hnRNPA2B1) has
been demonstrated to control the loading of certain miRNAs into
exosomes through recognition of specific short motifs [55]. These au-
thors have demonstrated that SUMO conjugation controls the interac-
tion of hnRNAPA2B1 with RNA molecules [55]. Sumoylation and
phosphorylation are associated events. There are many examples in
the literature where the sumoylation enables the interaction of kinases
resulting in the phosphorylation and activation/inhibition of the pro-
tein. These and other evidences suggest that the RNA-binding site
RPSSRASSRASSR may play an important role in the loading of RNA/
DNA/protein complexes acting as a platform through which connexin-
binding partners could interact. Besides, there are two matrix
metalloproteinase-7 (MMP-7) cleaved sites at the A357-I358 and
D379-L380 residues [56]. These two cut sites in the Cx43 protein
(LAIVDRPSSRASSRASSRPRPDDL) would generate a free C-terminal pep-
tide containing the DNA- and RNA-binding motifs (Figs. 1A and 4A).
3.2. Hydrophobicity of connexin domains
The members of the connexin family have similar topologies, and
each domain has differential functional roles. For example, the EC
loops facilitate the binding of one connexon to a connexon on an adja-
cent cell to form aGJ channel [57]. TheNTD is a key component in gating
[58]. The CL and CTD regulate channel activity depending on environ-
mental factors such as cytoplasmic pH or calcium concentration [59,
60]. The CTD is also a critical regulatory region essential for channel-de-
pendent and channel-independent functions of the protein [61–64].
The structure and amino acid sequences of Cxs are highly conserved,
but the cytoplasmic domains vary considerably between different iso-
forms, differing mainly in the sequence and lengths of the CL and CTD.
For example, Cx26 contains a shorter CTD compared to Cx43. The over-
all ribbon structure of the Cx26 monomer and the hexameric
hemichannel are shown in Fig. 2B and D, respectively. The different col-
ours show the RNA-bindingmotifs located in different protein domains.
The RNA-binding motifs located in the CL are represented in green,
while those in the CTD are represented in purple. Note that the studies
of Maeda et al. only describe the structure of a small sequence of the
Cx26 CTD [38]. The hydrophobicity of the Cx26 monomer and the
hemichannel are shown in Fig. 2C and E. As expected, the extracellular
and cytoplasmic axial views show that hydrophilic residues (blue) are
oriented towards the central axial pore, which allows the transfer of
ions and small signalling molecules with relatively low specificity. Hy-
drophilic areas are also concentrated in the cytoplasmic and extracellu-
lar domains. The predicted RNA-binding domains coincidewith some of
these hydrophilic regions (dashed circles) (Fig. 2C), suggesting that the
positively charged amino acid residues could form ionic bonds with
negatively charged phosphate groups. Other types of interactions such
as electrostatic interactions may be involved in this binding.
3.3. Functional cooperation between RNA-binding motifs
Most RNA-binding proteins contain several domains, including dif-
ferent types of RNA-binding motifs, which seem to be highly versatile
and structurally diverse. Many proteins containing different RNA-bind-
ingmotifs do not interact with each other and appear to bind RNA inde-
pendently. However, other proteins recognize RNA sequences with aspecific affinity that would not be possible for a single domain or with-
out the cooperation of multiple domains. For example, multiple do-
mains are capable interacting simultaneously with different sequences
of the same RNA (long RNAs) separated bymany nucleotides. The teth-
ering of domains (polypeptides) to create a larger binding interface usu-
ally improves the attachment of RNA to the protein [65].
Interestingly, some Cx domains with predicted RNA-binding motifs
structurally interact with each other. For example, the cytoplasmic
NTD has been described to play a critical role in channel gating as part
of the transjunctional voltage sensor [66–68] and interacts with trans-
membrane domain M1 (Supp. Fig. 3A). Electron cryo-crystallography,
X-ray diffraction [38] and cryo-electron microscopy [37] demonstrated
the presence of a plug created by the folding of the NTD fold into the
channel (M1 domain). The presence of a plug has been suggested to
physically block the channelwithin themembrane. The structural inter-
action between the NTD and M1 changes conformation depending on
gating, but nevertheless occurs whether the channel is open or closed
[69] (Supp. Fig. 3A). On the other hand, the M1 domain of Cx26 is re-
quired for hexamer formation and channel function [70]. Deafness-as-
sociated Cx26 mutations in the M1 domain affect the assembly and
functioning of hemichannels and GJs [70]. It is possible that the binding
of RNA to theNTD (and/orM1) could be implicated in the attachment or
sequestering of long RNAs to the membrane and/or in the transport of
small RNAs, such as microRNAs, through the pore [71,72].
An interaction between the cytoplasmic loop (CL) and plug loop of
Cx26 has been described to regulate the complex gating mechanism of
these channels [48,73,74]. Therefore, it cannot be ruled out that struc-
tural interactions described between the NTD, the M1 and the CL
could simultaneously mediate or enhance the interaction with RNA
sequences.
E1 and E2 are located on the extracellular face of connexons andmay
thus theoretically interactwith extracellular small RNAs that are not en-
capsulated within vesicles but are protected against RNase digestion by
associationwith other proteins [75] (Fig. 3 and Supp. Fig. 3B). The inter-
action of these RNAs (represented as fuchsia and blue lines)with the ex-
tracellular loops of the connexon could be implicated in intercellular
communication by the transference of the small RNA (fuchsia line) di-
rectly into the cell through the pore of the channel [71,76]. However,
these interactions may also be involved in intercellular communication
by the binding and recruitment of longer extracellular RNAs (blue lines)
to membrane vesicles, such as exosomes, while these vesicles travel
through the extracellular space (Fig. 3B). Several other species of intra-
cellular RNA that interact with the cytoplasmic domains (CL and CTD)
may also form part of this complex intercellular communication
through single membrane or double membrane vesicles (Fig. 3A–B).
The intramolecular interaction between the CL and CTD affects the ac-
tivity of the channels [77,78] and, together or individually, may also be
implicated in the recruitment of different species of RNA.
Exosomes contain mostly the molecular constituents of their cell of
origin. Nucleic acid binding is the most common function among pro-
teins extracted fromMVs/exosomes [79–81]. Each RNA- and DNA-bind-
ing protein has specific and differential functions. For example, the
synaptotagmin-binding cytoplasmic RNA-interacting protein
(SYNCRIP) or hnRNPA2B1 have been demonstrated to control the load-
ing of certain miRNAs into exosomes through recognition of specific
short motifs [55,82]. However the molecular mechanisms of loading
RNA and DNA molecules into exosomes remain elusive.
4. Membrane vesicles containing connexons
Cxs have high turnover rates, with half-lives ranging from 1.5 to 5 h
[40,83–86].When connexons of two opposing cells have docked to form
double-membrane GJ channels and plaques, they are inseparable under
physiological conditions [87,88]. The removal of these GJ channels from
the plasma membrane occurs through the internalization of the chan-
nels (docked connexons) within one of the coupled cells through a
Fig. 3. Potential functional roles of the RNA-binding motifs. The image exemplifies the transfer of molecules from one cell to another via membrane vesicle trafficking. (A) Double-
membrane vesicles (annular gap junctions) may allow the direct transfer of RNAs (purple and blue lines), proteins (red) and other molecules (blue circle) through mechanisms that
involve the trafficking of vesicles from the donor to the contacting recipient cell. (B) Cellular communication via single membrane vesicles containing Cxs (connexons) may also
enhance the transfer of several species of cytoplasmic and extracellular RNAs (purple and blue lines).
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cle or connexosome [87,89] (Fig. 3A). It has been widely accepted that
these annular gap junction vesicles are targeted for degradation by
autophagosomal and endo-lysosomal pathways [40,90]. However, this
field remains controversial, and future studies are needed to define
the biological importance of the direct uptake of double membrane
structures containing connexin channels [91]. These hexameric
connexons accommodate different molecules, including proteins at-
tached to the cytoplasmic domains [92,93]. Through membrane vesi-
cles, Cx43 binding partners that form macromolecular complexes [51,
92] may serve as a scaffold to transfer information, facilitate transport
mechanisms or regulate signalling pathways.
Cx expression and GJ intercellular communication (GJIC) are regu-
lated during the cell cycle [8]. Plaques of Cx43 have been detected in
the plasma membrane during the S and G2 phases, and these cells
show increased GJIC (as visualized by dye transfer) compared to cells
in G0/G1 [94,95]. Additionally, decreased GJIC [96,97] associated with
high levels of Cx43 phosphorylation [98,99], as well as the presence of
large vesicular clusters of Cx43 in the cytoplasm [97,99], have also
been observed during mitosis. The functional consequences and the ul-
timate fate of the cytoplasmic double membrane Cx43-vesicles during
and after mitosis are not yet clear.
Cxs have also been identified on single membrane vesicles derived
from various sources, referred to as exosomes [16,18]. In addition, Cxs
have been included in the composition of membrane vesicles designed
to mimic the protein content of exosomes to create amore effective de-
livery particle [100]. The presence of Cx43 on these membrane vesicles
increases the efficacy of liposomes in delivering anti-inflammatory pep-
tides into Cx43-expressing cells, suggesting that delivery is dependent
on Cx43 expression in the recipient cells [16]. This and other evidence
indicate that Cx43participates in intercellular communication involving
membrane vesicles.
5. Horizontal transfer of DNA fragments
Intriguingly, cytoplasmic DNA that originates in the genome but re-
mains associated with the plasmamembrane has been described [101].
These DNA fragments have become of interest for the study of innateimmunity, particularly in the case of lupus erythaematosus [102].
Deep sequencing studies have demonstrated that these DNA fragments
probably originate from the centromeric and pericentromeric regions of
all chromosomes and are precisely removed [103]. These studies have
also demonstrated that this DNA can be transcribed at the plasmamem-
brane by RNA polymerase II converted at this site into RNA. The physi-
ological roles of these DNA and RNA transcripts remain uncertain.
The BindN+ and DP-Bind computational methods [43,104] predict-
ed several DNA-binding sites in the Cx43 and Cx26 sequences located in
the NTD, E2 and CTD that could directly participate in the anchoring of
DNA to the membrane (Fig. 4 and Supp. Fig. 2). It would be interesting
to investigate if Cxs, particularly Cx43 and Cx26, are involved in the
modulation of signal transduction in the same cell or in the target cell.
6. RNA metabolism and gene expression
Others andwehave previously found that proteins that interactwith
Cx43 participate in RNA-related processes [92,105] such as transcrip-
tion, splicing, processing, transport and RNA chaperones by helping
the RNA to form secondary or tertiary structures [92,105]. Proteins con-
taining one or more RNA-binding domains have a variety of RNA bind-
ing preferences and functions and are involved in each step of RNA
metabolism including splicing, processing, transport and localization.
Besides, these structured RNAs can act as a signal for other RNA-binding
proteins (RBPs) that mediate gene regulation. Thus, Cxs through their
RNA-binding domains may be involved in RNA metabolism and a syn-
chronized protein production by orchestrating protein-RNA complexes
in the same cell or in the target cell. Additionally, several reports have
suggested that Cx43 regulates gene transcription, but the mechanism
has not yet been described. We cannot also disregard the possibility
that Cxs may interact with and recruit extracellular DNA involved in in-
nate immunity, the activation of inflammatory pathways, cancer or the
spread of cell damage [106–111] through the DNA-binding motif locat-
ed in extracellular loop EL2 (Fig. 4 and Supp. Fig. 2).
The potential activity of individual DNA-bindingmotifs (peptides re-
leased by physiological cleavage) [56,64] may be a powerful tool capa-
ble of binding specific DNA sites to control gene expression or
chromatin structure [112,113]. Several peptides (in the Cx43 sequence)
Fig. 4. Predicted DNA-bindingmotifs in the Cx43 and Cx26 sequences. The topological diagrams show the amino acid sequence of Cx43 (A) and Cx26 (B) with the predictedDNA-binding
residues (highlighted in green) using the BindN+ (specificity: 85%) and DP-Bind (probability N0.5) computational tools (see Suppl. Fig. 2).
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for cardiac reperfusion injury in heart attack patients, tissue regenera-
tion and wound healing or narcolepsy [114]. Further studies will clarify
the role played by Cxs and their peptides in the regulation of gene ex-
pression, chromatin structure and RNA metabolism.
7. Concluding remarks
Here, we identify several potential RNA- and DNA-binding motifs in
the sequences of Cx43 and Cx26. Whether these putative motifs have
any function in vivo remains unknown at this stage. However, the loca-
tion of the motifs, together with the known function of connexins,
makes this an intriguing possibility for future research. A full under-
standing of how these putative binding motifs might be involved in
connexin and microvesicles functions will require detailed studies that
include functional and structural characterization. We expect that fu-
ture analyses will expand on the diverse functions of connexins and
identify which specific RNA or DNA molecules bind to regulate cellular
signalling and the differential roles of connexins, especially during
tumourigenesis and metastasis. Furthermore, Cx-positive vesicles have
valuable potential as a therapeutic resource for drug delivery vehicles,
improving molecular transport across the plasma membrane barrier.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2017.02.001.
Author contributions
MV-E performed the analysis and prepared the Figs. AV-V, MR-C-M
and AV-S provided technical support. EF provided helpful suggestions.
AV-S, JLM and EV provided critical input. MDM made the originalobservation and wrote the paper. All authors discussed the data and
commented on the manuscript.
Conflict of interest
The authors have no conflicts of interest to declare.
Transparency document
The Transparency document associated with this article can be
found, in the online version.
Acknowledgements
This work was supported in part through funding from the Society
for Research on Bone and Mineral Metabolism - Grant number
FEIOMM2016 (to M.D.M.), by grant PRECIPITA-2015-000139 from the
FECYT-Ministry of Economy and Competitiveness (to M.D.M), by grants
PI13/00591 and PI16/00035 from the Health Institute “Carlos III” (ISCIII,
Spain) and co-financed by the European Regional Development Fund,
“A way of making Europe” from the European Union (to M.D.M.), by a
grant from Xunta de Galicia (pre-doctoral fellowship) to M.V.-E., and
by a grant from the Ministry of Education, Culture and Sports, Spain
(FPU grant to M.R.-C.M.). We thank members of the CellCOM group
for helpful technical suggestions.
References
[1] Y. Panchin, I. Kelmanson, M. Matz, K. Lukyanov, N. Usman, S. Lukyanov, A ubiqui-
tous family of putative gap junction molecules, Curr. Biol. 10 (2000) R473–R474.
[2] P. Phelan, Innexins: members of an evolutionarily conserved family of gap-junc-
tion proteins, Biochim. Biophys. Acta 1711 (2005) 225–245.
735M. Varela-Eirin et al. / Biochimica et Biophysica Acta 1864 (2017) 728–736[3] G. Sohl, K. Willecke, Gap junctions and the connexin protein family, Cardiovasc.
Res. 62 (2004) 228–232.
[4] A. Plum, G. Hallas, T. Magin, F. Dombrowski, A. Hagendorff, B. Schumacher, C.
Wolpert, J. Kim, W.H. Lamers, M. Evert, P. Meda, O. Traub, K. Willecke, Unique
and shared functions of different connexins in mice, Curr. Biol. 10 (2000)
1083–1091.
[5] A.L. Harris, Emerging issues of connexin channels: biophysics fills the gap, Q. Rev.
Biophys. 34 (2001) 325–472.
[6] G.S. Goldberg, P.D. Lampe, B.J. Nicholson, Selective transfer of endogenous metab-
olites through gap junctions composed of different connexins, Nat. Cell Biol. 1
(1999) 457–459.
[7] D.W. Laird, Life cycle of connexins in health and disease, Biochem. J. 394 (2006)
527–543.
[8] J.L. Solan, P.D. Lampe, Connexin43 phosphorylation: structural changes and biolog-
ical effects, Biochem. J. 419 (2009) 261–272.
[9] W.A. Paznekas, B. Karczeski, S. Vermeer, R.B. Lowry, M. Delatycki, F. Laurence, P.A.
Koivisto, L. Van Maldergem, S.A. Boyadjiev, J.N. Bodurtha, E.W. Jabs, GJA1 muta-
tions, variants, and connexin 43 dysfunction as it relates to the oculodentodigital
dysplasia phenotype, Hum. Mutat. 30 (2009) 724–733.
[10] E.L.A. S, I. Mager, X.O. Breakefield, M.J. Wood, Extracellular vesicles: biology and
emerging therapeutic opportunities, Nat Rev Drug Discov 12 (2013) 347–357.
[11] M. Tkach, C. Thery, Communication by extracellular vesicles: where we are and
where we need to go, Cell 164 (2016) 1226–1232.
[12] I. Del Conde, C.N. Shrimpton, P. Thiagarajan, J.A. Lopez, Tissue-factor-bearing
microvesicles arise from lipid rafts and fuse with activated platelets to initiate co-
agulation, Blood 106 (2005) 1604–1611.
[13] K. Miyazawa, K. Emmerling, L. Manuelidis, Proliferative arrest of neural cells in-
duces prion protein synthesis, nanotube formation, and cell-to-cell contacts, J.
Cell. Biochem. 111 (2010) 239–247.
[14] L.A. Mulcahy, R.C. Pink, D.R. Carter, Routes and mechanisms of extracellular vesicle
uptake, J. Extracell. Vesicles 3 (2014).
[15] A.K. Gadok, D.J. Busch, S. Ferrati, B. Li, H.D. Smyth, J.C. Stachowiak, Connectosomes
for direct molecular delivery to the cellular cytoplasm, J. Am. Chem. Soc. (2016).
[16] M. Kaneda, S.M. Nomura, S. Ichinose, S. Kondo, K. Nakahama, K. Akiyoshi, I.
Morita, Direct formation of proteo-liposomes by in vitro synthesis and cellular
cytosolic delivery with connexin-expressing liposomes, Biomaterials 30
(2009) 3971–3977.
[17] M. Simons, G. Raposo, Exosomes–vesicular carriers for intercellular communica-
tion, Curr. Opin. Cell Biol. 21 (2009) 575–581.
[18] A.R. Soares, T. Martins-Marques, T. Ribeiro-Rodrigues, J.V. Ferreira, S. Catarino, M.J.
Pinho, M. Zuzarte, S. Isabel Anjo, B. Manadas, P.G.S. J, P. Pereira, H. Girao, Gap junc-
tional protein Cx43 is involved in the communication between extracellular vesi-
cles and mammalian cells, Sci. Rep. 5 (2015) 13243.
[19] S.J. Webb, Supramolecular approaches to combiningmembrane transport with ad-
hesion, Acc. Chem. Res. 46 (2013) 2878–2887.
[20] J.S. Schorey, S. Bhatnagar, Exosome function: from tumor immunology to pathogen
biology, Traffic 9 (2008) 871–881.
[21] K. Skriner, K. Adolph, P.R. Jungblut, G.R. Burmester, Association of citrullinated pro-
teins with synovial exosomes, Arthritis Rheum. 54 (2006) 3809–3814.
[22] J. Skog, T. Wurdinger, S. van Rijn, D.H. Meijer, L. Gainche, M. Sena-Esteves, W.T.
Curry Jr., B.S. Carter, A.M. Krichevsky, X.O. Breakefield, Glioblastoma microvesicles
transport RNA and proteins that promote tumour growth and provide diagnostic
biomarkers, Nat. Cell Biol. 10 (2008) 1470–1476.
[23] L.J. Vella, R.A. Sharples, R.M. Nisbet, R. Cappai, A.F. Hill, The role of exosomes in the
processing of proteins associated with neurodegenerative diseases, Eur. Biophys. J.
37 (2008) 323–332.
[24] D.M. Pegtel, K. Cosmopoulos, D.A. Thorley-Lawson, M.A. van Eijndhoven, E.S.
Hopmans, J.L. Lindenberg, T.D. de Gruijl, T. Wurdinger, J.M. Middeldorp, Functional
delivery of viral miRNAs via exosomes, Proc. Natl. Acad. Sci. U. S. A. 107 (2010)
6328–6333.
[25] M. Lenassi, G. Cagney, M. Liao, T. Vaupotic, K. Bartholomeeusen, Y. Cheng, N.J.
Krogan, A. Plemenitas, B.M. Peterlin, HIV Nef is secreted in exosomes and triggers
apoptosis in bystander CD4+ T cells, Traffic 11 (2010) 110–122.
[26] B. Fevrier, D. Vilette, F. Archer, D. Loew, W. Faigle, M. Vidal, H. Laude, G. Raposo,
Cells release prions in association with exosomes, Proc. Natl. Acad. Sci. U. S. A.
101 (2004) 9683–9688.
[27] P.J. Quesenberry, J. Aliotta, M.C. Deregibus, G. Camussi, Role of extracellular RNA-
carrying vesicles in cell differentiation and reprogramming, Stem Cell Res. Ther.
6 (2015) 153.
[28] S. Ramachandran, V. Palanisamy, Horizontal transfer of RNAs: exosomes as media-
tors of intercellular communication, Wiley Interdiscip. Rev. RNA 3 (2012)
286–293.
[29] M. Guescini, D. Guidolin, L. Vallorani, L. Casadei, A.M. Gioacchini, P. Tibollo, M.
Battistelli, E. Falcieri, L. Battistin, L.F. Agnati, V. Stocchi, C2C12 myoblasts release
micro-vesicles containing mtDNA and proteins involved in signal transduction,
Exp. Cell Res. 316 (2010) 1977–1984.
[30] M. Guescini, S. Genedani, V. Stocchi, L.F. Agnati, Astrocytes and glioblastoma cells
release exosomes carrying mtDNA, J. Neural Transm. 117 (2010) 1–4.
[31] D. Torralba, F. Baixauli, F. Sanchez-Madrid, Mitochondria know no boundaries:
mechanisms and functions of intercellular mitochondrial transfer, Front. Cell
Dev. Biol. 4 (2016) 107.
[32] H. Valadi, K. Ekstrom, A. Bossios, M. Sjostrand, J.J. Lee, J.O. Lotvall, Exosome-medi-
ated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange
between cells, Nat. Cell Biol. 9 (2007) 654–659.
[33] P.L. Sorgen, H.S. Duffy, P. Sahoo, W. Coombs, M. Delmar, D.C. Spray, Structural
changes in the carboxyl terminus of the gap junction protein connexin43 indicatessignaling between binding domains for c-Src and zonula occludens-1, J. Biol. Chem.
279 (2004) 54695–54701.
[34] P.L. Sorgen, H.S. Duffy, D.C. Spray, M. Delmar, pH-dependent dimerization of the
carboxyl terminal domain of Cx43, Biophys. J. 87 (2004) 574–581.
[35] V.M. Unger, N.M. Kumar, N.B. Gilula, M. Yeager, Three-dimensional structure
of a recombinant gap junction membrane channel, Science 283 (1999)
1176–1180.
[36] F. Zonta, D. Buratto, C. Cassini, M. Bortolozzi, F. Mammano, Molecular dynamics
simulations highlight structural and functional alterations in deafness-related
M34 T mutation of connexin 26, Front. Physiol. 5 (2014) 85.
[37] A. Oshima, K. Tani, Y. Hiroaki, Y. Fujiyoshi, G.E. Sosinsky, Three-dimensional struc-
ture of a human connexin26 gap junction channel reveals a plug in the vestibule,
Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 10034–10039.
[38] S. Maeda, S. Nakagawa, M. Suga, E. Yamashita, A. Oshima, Y. Fujiyoshi, T. Tsukihara,
Structure of the connexin 26 gap junction channel at 3.5 A resolution, Nature 458
(2009) 597–602.
[39] B.C. Bennett, M.D. Purdy, K.A. Baker, C. Acharya, W.E. McIntire, R.C. Stevens, Q.
Zhang, A.L. Harris, R. Abagyan, M. Yeager, An electrostatic mechanism for
Ca(2+)-mediated regulation of gap junction channels, Nat. Commun. 7 (2016)
8770.
[40] A.F. Thevenin, T.J. Kowal, J.T. Fong, R.M. Kells, C.G. Fisher, M.M. Falk, Proteins and
mechanisms regulating gap-junction assembly, internalization, and degradation,
Physiology (Bethesda) 28 (2013) 93–116.
[41] S. Li, K. Yamashita, K.M. Amada, D.M. Standley, Quantifying sequence and
structural features of protein-RNA interactions, Nucleic Acids Res. 42 (2014)
10086–10098.
[42] M. Kumar, M.M. Gromiha, G.P. Raghava, Prediction of RNA binding sites in a pro-
tein using SVM and PSSM profile, Proteins 71 (2008) 189–194.
[43] L. Wang, C. Huang, M.Q. Yang, J.Y. Yang, BindN+ for accurate prediction of DNA
and RNA-binding residues from protein sequence features, BMC Syst. Biol. 4
(Suppl. 1) (2010) S3.
[44] V.M. Unger, N.M. Kumar, N.B. Gilula, M. Yeager, Projection structure of a gap junc-
tion membrane channel at 7 A resolution, Nat. Struct. Biol. 4 (1997) 39–43.
[45] M. Yeager, Structure of cardiac gap junction intercellular channels, J. Struct. Biol.
121 (1998) 231–245.
[46] T.A. Bargiello, Q. Tang, S. Oh, T. Kwon, Voltage-dependent conformational changes
in connexin channels, Biochim. Biophys. Acta 1818 (2012) 1807–1822.
[47] T. Kwon, A.L. Harris, A. Rossi, T.A. Bargiello, Molecular dynamics simulations of the
Cx26 hemichannel: evaluation of structural models with Brownian dynamics, J.
Gen. Physiol. 138 (2011) 475–493.
[48] A. Oshima, K. Tani, M.M. Toloue, Y. Hiroaki, A. Smock, S. Inukai, A. Cone, B.J.
Nicholson, G.E. Sosinsky, Y. Fujiyoshi, Asymmetric configurations and N-terminal
rearrangements in connexin26 gap junction channels, J. Mol. Biol. 405 (2011)
724–735.
[49] T.S. Bayer, L.N. Booth, S.M. Knudsen, A.D. Ellington, Arginine-rich motifs
present multiple interfaces for specific binding by RNA, RNA 11 (2005)
1848–1857.
[50] A.I. Jarvelin, M. Noerenberg, I. Davis, A. Castello, The new (dis)order in RNA regu-
lation, Cell Commun. Signal 14 (2016) 9.
[51] J.C. Herve, M. Derangeon, D. Sarrouilhe, B.N. Giepmans, N. Bourmeyster, Gap junc-
tional channels are parts of multiprotein complexes, Biochim. Biophys. Acta 1818
(2012) 1844–1865.
[52] J.A. Palatinus, J.M. Rhett, R.G. Gourdie, The connexin43 carboxyl terminus and car-
diac gap junction organization, Biochim. Biophys. Acta 1818 (2012) 1831–1843.
[53] B.N. Giepmans, Gap junctions and connexin-interacting proteins, Cardiovasc. Res.
62 (2004) 233–245.
[54] K. Pogoda, P. Kameritsch, M.A. Retamal, J.L. Vega, Regulation of gap junction chan-
nels and hemichannels by phosphorylation and redox changes: a revision, BMC
Cell Biol. 17 (Suppl. 1) (2016) 11.
[55] C. Villarroya-Beltri, C. Gutierrez-Vazquez, F. Sanchez-Cabo, D. Perez-Hernandez, J.
Vazquez, N. Martin-Cofreces, D.J. Martinez-Herrera, A. Pascual-Montano, M.
Mittelbrunn, F. Sanchez-Madrid, Sumoylated hnRNPA2B1 controls the sorting of
miRNAs into exosomes through binding to specific motifs, Nat. Commun. 4
(2013) 2980.
[56] M.L. Lindsey, G.P. Escobar, R. Mukherjee, D.K. Goshorn, N.J. Sheats, J.A. Bruce, I.M.
Mains, J.K. Hendrick, K.W. Hewett, R.G. Gourdie, L.M. Matrisian, F.G. Spinale, Matrix
metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival
after myocardial infarction, Circulation 113 (2006) 2919–2928.
[57] J.C. Herve, M. Derangeon, B. Bahbouhi, M. Mesnil, D. Sarrouilhe, The connexin turn-
over, an important modulating factor of the level of cell-to-cell junctional commu-
nication: comparison with other integral membrane proteins, J. Membr. Biol. 217
(2007) 21–33.
[58] P.E. Purnick, S. Oh, C.K. Abrams, V.K. Verselis, T.A. Bargiello, Reversal of the gating
polarity of gap junctions by negative charge substitutions in the N-terminus of
connexin 32, Biophys. J. 79 (2000) 2403–2415.
[59] J.F. Ek, M. Delmar, R. Perzova, S.M. Taffet, Role of histidine 95 on pH gating of the
cardiac gap junction protein connexin43, Circ. Res. 74 (1994) 1058–1064.
[60] J.F. Ek-Vitorin, G. Calero, G.E. Morley, W. Coombs, S.M. Taffet, M. Delmar, pH regu-
lation of connexin43: molecular analysis of the gating particle, Biophys. J. 71
(1996) 1273–1284.
[61] X. Dang, B.W. Doble, E. Kardami, The carboxy-tail of connexin-43 localizes to the
nucleus and inhibits cell growth, Mol. Cell. Biochem. 242 (2003) 35–38.
[62] J.L. Shin, J.L. Solan, P.D. Lampe, The regulatory role of the C-terminal domain of
connexin43, Cell Commun. Adhes. 8 (2001) 271–275.
[63] Y.W. Zhang, M. Kaneda, I. Morita, The gap junction-independent tumor-suppress-
ing effect of connexin 43, J. Biol. Chem. 278 (2003) 44852–44856.
736 M. Varela-Eirin et al. / Biochimica et Biophysica Acta 1864 (2017) 728–736[64] M. De Bock, N. Wang, E. Decrock, G. Bultynck, L. Leybaert, Intracellular cleavage of
the Cx43 C-terminal domain by matrix-metalloproteases: a novel contributor to
inflammation? Mediat. Inflamm. 2015 (2015) 257471.
[65] B.M. Lunde, C. Moore, G. Varani, RNA-binding proteins: modular design for effi-
cient function, Nat. Rev. Mol. Cell Biol. 8 (2007) 479–490.
[66] S. Oh, C.K. Abrams, V.K. Verselis, T.A. Bargiello, Stoichiometry of transjunctional
voltage-gating polarity reversal by a negative charge substitution in the amino ter-
minus of a connexin32 chimera, J. Gen. Physiol. 116 (2000) 13–31.
[67] S. Oh, S. Rivkin, Q. Tang, V.K. Verselis, T.A. Bargiello, Determinants of gating polarity
of a connexin 32 hemichannel, Biophys. J. 87 (2004) 912–928.
[68] V.K. Verselis, C.S. Ginter, T.A. Bargiello, Opposite voltage gating polarities of two
closely related connexins, Nature 368 (1994) 348–351.
[69] A. Oshima, Structure and closure of connexin gap junction channels, FEBS Lett. 588
(2014) 1230–1237.
[70] O. Jara, R. Acuna, I.E. Garcia, J. Maripillan, V. Figueroa, J.C. Saez, R. Araya-Secchi, C.F.
Lagos, T. Perez-Acle, V.M. Berthoud, E.C. Beyer, A.D. Martinez, Critical role of the
first transmembrane domain of Cx26 in regulating oligomerization and function,
Mol. Biol. Cell 23 (2012) 3299–3311.
[71] V. Valiunas, Y.Y. Polosina, H. Miller, I.A. Potapova, L. Valiuniene, S. Doronin, R.T.
Mathias, R.B. Robinson, M.R. Rosen, I.S. Cohen, P.R. Brink, Connexin-specific cell-
to-cell transfer of short interfering RNA by gap junctions, J. Physiol. 568 (2005)
459–468.
[72] M.D. Mayan, R. Gago-Fuentes, P. Carpintero-Fernandez, P. Fernandez-Puente, P.
Filgueira-Fernandez, N. Goyanes, V. Valiunas, P.R. Brink, G.S. Goldberg, F.J. Blanco,
Articular chondrocyte network mediated by gap junctions: role in metabolic carti-
lage homeostasis, Ann. Rheum. Dis. 74 (2015) 275–284.
[73] S. Oh, J.B. Rubin, M.V. Bennett, V.K. Verselis, T.A. Bargiello, Molecular determinants
of electrical rectification of single channel conductance in gap junctions formed by
connexins 26 and 32, J. Gen. Physiol. 114 (1999) 339–364.
[74] Y. Fujiyoshi, Structural physiology based on electron crystallography, Protein Sci.
20 (2011) 806–817.
[75] A.M. Hoy, A.H. Buck, Extracellular small RNAs: what, where, why? Biochem. Soc.
Trans. 40 (2012) 886–890.
[76] P.R. Brink, V. Valiunas, C. Gordon, M.R. Rosen, I.S. Cohen, Can gap junctions deliver?
Biochim. Biophys. Acta 1818 (2012) 2076–2081.
[77] H.S. Duffy, P.L. Sorgen, M.E. Girvin, P. O'Donnell,W. Coombs, S.M. Taffet, M. Delmar,
D.C. Spray, pH-dependent intramolecular binding and structure involving Cx43 cy-
toplasmic domains, J. Biol. Chem. 277 (2002) 36706–36714.
[78] R. Ponsaerts, E. De Vuyst, M. Retamal, C. D'Hondt, D. Vermeire, N. Wang, H. De
Smedt, P. Zimmermann, B. Himpens, J. Vereecke, L. Leybaert, G. Bultynck, Intramo-
lecular loop/tail interactions are essential for connexin 43-hemichannel activity,
FASEB J. 24 (2010) 4378–4395.
[79] M.P. Zaborowski, L. Balaj, X.O. Breakefield, C.P. Lai, Extracellular vesicles: composi-
tion, biological relevance, and methods of study, Bioscience 65 (2015) 783–797.
[80] A. Sinha, V. Ignatchenko, A. Ignatchenko, S. Mejia-Guerrero, T. Kislinger, In-depth
proteomic analyses of ovarian cancer cell line exosomes reveals differential enrich-
ment of functional categories compared to the NCI 60 proteome, Biochem. Biophys.
Res. Commun. 445 (2014) 694–701.
[81] T. Janas, M.M. Janas, K. Sapon, T. Janas, Mechanisms of RNA loading into exosomes,
FEBS Lett. 589 (2015) 1391–1398.
[82] L. Santangelo, G. Giurato, C. Cicchini, C. Montaldo, C. Mancone, R. Tarallo, C.
Battistelli, T. Alonzi, A. Weisz, M. Tripodi, The RNA-binding protein SYNCRIP is a
component of the hepatocyte exosomal machinery controlling microRNA sorting,
Cell Rep. 17 (2016) 799–808.
[83] M.A. Beardslee, J.G. Laing, E.C. Beyer, J.E. Saffitz, Rapid turnover of connexin43 in
the adult rat heart, Circ. Res. 83 (1998) 629–635.
[84] V.M. Berthoud, P.J. Minogue, J.G. Laing, E.C. Beyer, Pathways for degradation of
connexins and gap junctions, Cardiovasc. Res. 62 (2004) 256–267.
[85] R.F. Fallon, D.A. Goodenough, Five-hour half-life of mouse liver gap-junction pro-
tein, J. Cell Biol. 90 (1981) 521–526.
[86] J.L. Solan, P.D. Lampe, Key connexin 43 phosphorylation events regulate the gap
junction life cycle, J. Membr. Biol. 217 (2007) 35–41.
[87] S. Ghoshroy, D.A. Goodenough, G.E. Sosinsky, Preparation, characterization, and
structure of half gap junctional layers split with urea and EGTA, J. Membr. Biol.
146 (1995) 15–28.
[88] D.A. Goodenough, N.B. Gilula, The splitting of hepatocyte gap junctions and zonu-
lae occludentes with hypertonic disaccharides, J. Cell Biol. 61 (1974) 575–590.
[89] K. Jordan, R. Chodock, A.R. Hand, D.W. Laird, The origin of annular junctions: a
mechanism of gap junction internalization, J. Cell Sci. 114 (2001) 763–773.
[90] G. Spagnol, F. Kieken, J.L. Kopanic, H. Li, S. Zach, K.L. Stauch, R. Grosely, P.L. Sorgen,
Structural studies of the Nedd4WWdomains and their selectivity for the Cx43 car-
boxyl-terminus, J. Biol. Chem. (2016).[91] M.M. Falk, C.L. Bell, R.M. Kells Andrews, S.A. Murray, Molecular mechanisms regu-
lating formation, trafficking and processing of annular gap junctions, BMC Cell Biol.
17 (Suppl. 1) (2016) 22.
[92] R. Gago-Fuentes, P. Fernandez-Puente, D. Megias, P. Carpintero-Fernandez, J.
Mateos, B. Acea, E. Fonseca, F.J. Blanco, M.D. Mayan, Proteomic analysis of connexin
43 reveals novel interactors related to osteoarthritis, Mol. Cell. Proteomics 14
(2015) 1831–1845.
[93] D.W. Laird, The gap junction proteome and its relationship to disease, Trends Cell
Biol. 20 (2010) 92–101.
[94] K.S. Bittman, J.J. LoTurco, Differential regulation of connexin 26 and 43 in murine
neocortical precursors, Cereb. Cortex 9 (1999) 188–195.
[95] D. Singh, J.L. Solan, S.M. Taffet, R. Javier, P.D. Lampe, Connexin 43 interacts with
zona occludens-1 and -2 proteins in a cell cycle stage-specific manner, J. Biol.
Chem. 280 (2005) 30416–30421.
[96] L.S. Stein, J. Boonstra, R.C. Burghardt, Reduced cell-cell communication between
mitotic and nonmitotic coupled cells, Exp. Cell Res. 198 (1992) 1–7.
[97] H. Xie, D.W. Laird, T.H. Chang, V.W. Hu, A mitosis-specific phosphorylation of the
gap junction protein connexin43 in human vascular cells: biochemical characteri-
zation and localization, J. Cell Biol. 137 (1997) 203–210.
[98] M.Y. Kanemitsu, W. Jiang, W. Eckhart, Cdc2-mediated phosphorylation of the gap
junction protein, connexin43, during mitosis, Cell Growth Differ. 9 (1998) 13–21.
[99] P.D. Lampe, W.E. Kurata, B.J. Warn-Cramer, A.F. Lau, Formation of a distinct
connexin43 phosphoisoform in mitotic cells is dependent upon p34cdc2 kinase,
J. Cell Sci. 111 (Pt 6) (1998) 833–841.
[100] S. Lakhal, S.E. Andaloussi, O.J. O'Loughlin, J. Li, M.M.J. Wood, RNAi therapeutic deliv-
ery by exosomes, in: K.A. Howard (Ed.), RNA Interference from Biology to Thera-
peutics, Place Published, Spriger 2013, pp. 185–207.
[101] R.A. Lerner, W. Meinke, D.A. Goldstein, Membrane-associated DNA in the cyto-
plasm of diploid human lymphocytes, Proc. Natl. Acad. Sci. U. S. A. 68 (1971)
1212–1216.
[102] G. Servais, M.P. Guillaume, N. Dumarey, J. Duchateau, Evidence of autoantibodies to
cell membrane associated DNA (cultured lymphocytes): a new specific marker for
rapid identification of systemic lupus erythematosus, Ann. Rheum. Dis. 57 (1998)
606–613.
[103] J. Cheng, A. Torkamani, Y. Peng, T.M. Jones, R.A. Lerner, Plasma membrane associ-
ated transcription of cytoplasmic DNA, Proc. Natl. Acad. Sci. U. S. A. 109 (2012)
10827–10831.
[104] S. Hwang, Z. Gou, I.B. Kuznetsov, DP-Bind: a web server for sequence-based predic-
tion of DNA-binding residues in DNA-binding proteins, Bioinformatics 23 (2007)
634–636.
[105] T. Martins-Marques, S.I. Anjo, P. Pereira, B. Manadas, H. Girao, Interacting network
of the gap junction (GJ) protein connexin43 (Cx43) is modulated by ischemia and
reperfusion in the heart, Mol. Cell. Proteomics 14 (2015) 3040–3055.
[106] A.V. Ermakov, M.S. Konkova, S.V. Kostyuk, V.L. Izevskaya, A. Baranova, N.N. Veiko,
Oxidized extracellular DNA as a stress signal in human cells, Oxidative Med. Cell.
Longev. 2013 (2013) 649747.
[107] S. Frese, B. Diamond, Structural modification of DNA—a therapeutic option in SLE?
Nat. Rev. Rheumatol. 7 (2011) 733–738.
[108] K. Glebova, N. Veiko, S. Kostyuk, V. Izhevskaya, A. Baranova, Oxidized extracellular
DNA as a stress signal that maymodify response to anticancer therapy, Cancer Lett.
356 (2015) 22–33.
[109] M.C. Hawes, F.Wen, E. Elquza, Extracellular DNA: a bridge to cancer, Cancer Res. 75
(2015) 4260–4264.
[110] C. Lood, L.P. Blanco, M.M. Purmalek, C. Carmona-Rivera, S.S. De Ravin, C.K. Smith,
H.L. Malech, J.A. Ledbetter, K.B. Elkon, M.J. Kaplan, Neutrophil extracellular traps
enriched in oxidized mitochondrial DNA are interferogenic and contribute to
lupus-like disease, Nat. Med. 22 (2016) 146–153.
[111] S. Sandgren, A. Wittrup, F. Cheng, M. Jonsson, E. Eklund, S. Busch, M. Belting, The
human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nu-
clear compartment of mammalian cells via lipid rafts and proteoglycan-dependent
endocytosis, J. Biol. Chem. 279 (2004) 17951–17956.
[112] E. Pazos, C. Portela, C. Penas, M.E. Vazquez, J.L. Mascarenas, Peptide-DNA conju-
gates as tailored bivalent binders of the oncoprotein c-Jun, Org. Biomol. Chem.
13 (2015) 5385–5390.
[113] J. Rodriguez, J. Mosquera, R. Garcia-Fandino, M.E. Vazquez, J.L. Mascarenas, A de-
signed DNA binding motif that recognizes extended sites and spans two adjacent
major grooves, Chem. Sci. 7 (2016) 3298–3303.
[114] J.L. Esseltine, D.W. Laird, Next-generation connexin and pannexin cell biology,
Trends Cell Biol. (2016).
[115] J. Kyte, R.F. Doolittle, A simplemethod for displaying the hydropathic character of a
protein, J. Mol. Biol. 157 (1982) 105–132.
